Enalapril in heart failure: racial responses differ

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1287, 2001-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enalapril for heart failure well tolerated

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Racial Differences in Responses to Drug Treatment: Implications for Pharmacotherapy of Heart Failure

By Taylor J.S.W. Ellis G.R.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 6, 2002-01 ,pp. : 389-399

Adis International

Access to resources Recommend Favorite

Omapatrilat, enalapril similar improvements in heart failure

Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

High- vs low-dose enalapril in chronic heart failure

Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Altered neuropeptide Y Y 1 responses in mesenteric arteries in rats with congestive heart failure

By Bergdahl A. Nilsson T. Sun X.Y. Hedner T. Edvinsson L.

European Journal of Pharmacology, Vol. 360, Iss. 2, 1998-11 ,pp. : 165-173

Elsevier

Access to resources Recommend Favorite